Accord’s UK Lenalidomide Launch Kicks Off A Year Of Revlimid Competition
UK Generic Launch Comes Ahead Of Expected Rivals Elsewhere In Europe And US
Accord has confirmed the launch of a generic lenalidomide rival to Revlimid in the UK. The launch leads off a year that is expected to see the BMS blockbuster also face significant competition elsewhere in Europe and the US.
